Inactive Instrument

Other languages Trillium Therapeutics

Equities

TRIL

CA89620X5064

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

TCR2 Therapeutics Appoints Chief Business and Strategy Officer	22-01-12
Pfizer Eyes Enhanced Immuno-Inflammatory Disease Expertise With $6.7 Billion Arena Pharmaceuticals Takeover	21-12-13
Pfizer schluckt kalifornische Biotechfirma für 6,7 Mrd Dollar	21-12-13
Pfizer scommette su promettente farmaco Arena con deal da 6,7 mld $	21-12-13
Pfizer : a finalisé l'acquisition de Trillium Therapeutics	21-11-18
Pfizer Completes $2.22 Billion Trillium Therapeutics Acquisition	21-11-17
Pfizer-Trillium Therapeutics $2.26 Billion Deal Secures Canada, US Approval	21-11-17
Trillium Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12
++ Analysen des Tages von Dow Jones Newswires (26.08.2021) +++	21-08-26
Trackinsight: La hausse des prix du pétrole et de l’or propulse les actions canadiennes	21-08-24
Ose Immunotherapeutics : poursuit sur sa lancée grâce à Pfizer et Trillium	21-08-24
Wall Street ends higher on full vaccine approval	21-08-23
DJ Industrial : Nasdaq Starts Week at Record Levels as Pfizer COVID-19 Vaccine Gets FDA Full Approval	21-08-23
MÄRKTE USA/US-Daten, Impffortschritt und Fed-Fantasie beflügeln	21-08-23
Sector Update: Health Care Stocks Nudging Higher in Late Afternoon Trade	21-08-23
DJ Industrial : Equities Rise After FDA Grants Full Approval to Pfizer, BioNTech COVID-19 Vaccine	21-08-23
Sector Update: Health Care Stocks Led Higher By Biotech Shares	21-08-23
Midday Report: US Stocks Rise After FDA Grants Full Approval to Pfizer and BioNTech's COVID-19 Vaccine; Oil Surges	21-08-23
Dow Jones Industrial Average : Borsa Usa rimbalza su scia rialzo titoli bancari ed energetici	21-08-23
MÄRKTE USA/Freundlich - Wette auf taubenhafte Fed	21-08-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Trillium Therapeutics

Equities

TRIL

CA89620X5064

Other languages

Filters